Familial lipoprotein lipase deficiency in infancy:: Clinical, biochemical, and molecular study

被引:63
作者
Feoli-Fonseca, JC
Lévy, E
Godard, M
Lambert, M
机构
[1] Univ Montreal, Hop St Justine, Gen Med Serv, Montreal, PQ H3T 1C5, Canada
[2] Univ Montreal, Hop St Justine, Serv Gastroenterol, Dept Pediat, Montreal, PQ H3T 1C5, Canada
[3] Univ Montreal, Hop St Justine, Clin Nutr Serv, Montreal, PQ H3T 1C5, Canada
关键词
D O I
10.1016/S0022-3476(98)70280-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To describe the characteristics of lipoprotein lipase (LPL)-deficient patients seen in infancy and to evaluate the safety and efficacy of severe fat restriction. Methods: Children <1 year old presenting with chylomicronemia between 1972 and 1995 were identified, and their clinical courses were reviewed retrospectively. Results: LPL deficiency was demonstrated in 16 infants who presented with irritability (n = 7), lower intestinal bleeding (n = 2), pallor, anemia, or splenomegaly (n = 5), and a family history or fortuitous discovery (n = 2). All plasma samples were lactescent at presentation. Chylomicronemia responded rapidly to dietary fat restriction, and it was possible to maintain satisfactory metabolic control for a prolonged period of time. Only 1 adolescent girl had an episode of pancreatitis associated with the use of oral contraceptives. No persistent adverse effects on growth were seen. We obtained abnormal values for serum iron, alkaline phosphatase, and total calcium. Conclusions: The presentation of LPL deficiency is heterogeneous during infancy. Close dietary monitoring is required to avoid nutritional deficiencies. Estrogen therapy should be avoided in LPL-deficient patients.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 29 条
[1]   FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE [J].
AMEIS, D ;
KOBAYASHI, J ;
DAVIS, RC ;
BENZEEV, O ;
MALLOY, MJ ;
KANE, JP ;
LEE, G ;
WONG, H ;
HAVEL, RJ ;
SCHOTZ, MC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1165-1170
[2]  
[Anonymous], 1989, Molecular Cloning: A Laboratory Manual
[3]  
Benlian P, 1996, AM J HUM GENET, V59, P431
[4]  
BERGER GMB, 1977, S AFR MED J, V51, P623
[5]  
BIJVOET SM, 1992, HUM MOL GENET, V1, P541
[6]   DIETARY-TREATMENT AND GROWTH OF HYPERCHYLOMICRONEMIC CHILDREN SEVERELY RESTRICTED IN DIETARY-FAT [J].
BLACK, DM ;
SPRECHER, DL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (01) :60-62
[7]  
Brunzell JD, 1995, METABOLIC MOL BASES, P1913
[8]   HEMOLYSIS IN PRIMARY LIPOPROTEIN-LIPASE DEFICIENCY [J].
CANTIN, B ;
BOUDRIAU, S ;
BERTRAND, M ;
BRUN, LD ;
GAGNE, C ;
ROGERS, PA ;
VENMURTHY, MR ;
LUPIEN, PJ ;
JULIEN, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (05) :652-658
[9]  
DECHALAIN TMB, 1988, SURG GYNECOL OBSTET, V167, P469
[10]   PRIMARY HYPERTRIGLYCERIDEMIA IN CHILDHOOD [J].
DECKELBAUM, RJ ;
DUPONT, C ;
LETARTE, J ;
PENCHARZ, P .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (04) :396-398